Showing results (41-50 of 99) with videos related to

Sort By:
Pageof 10
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 31, 2011
Predictors of early and late outcomes after everolimus and paclitaxel-eluting coronary stentsRobert J Applegate, James B Hermiller, Paul C Gordon, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 28, 2010
Evaluation of the effects of everolimus-eluting and paclitaxel-eluting stents on target lesions with jailed side branches: 2-year results from the SPIRIT III randomized trialRobert Applegate, James Hermiller, Jerome Williams, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 2, 2010
Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients with two treated vessels: 2-year results from the SPIRIT III randomised trialRobert J Applegate, James J Hermiller, Mark Sanz, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 5, 2018
Three-year clinical outcomes of patients treated with everolimus-eluting bioresorbable vascular scaffolds: Final results of the ABSORB EXTEND trialJ Ribamar Costa, Alexandre Abizaid, Robert Whitbourn, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 7, 2011
Clinical and angiographic outcomes of elderly patients treated with everolimus-eluting versus paclitaxel-eluting stents: three-year results from the SPIRIT III randomised trialJames B Hermiller, Eugenia Nikolsky, Alexandra J Lansky, et al.
The American Journal of Cardiology|April 26, 2006
Location of focal vasospasm provoked by ergonovine maleate within coronary arteries in patients with vasospastic angina pectorisTomomi Koizumi, Masaki Yokoyama, Susumu Namikawa, et al.
American Heart Journal|September 29, 2009
SPIRIT IV trial design: a large-scale randomized comparison of everolimus-eluting stents and paclitaxel-eluting stents in patients with coronary artery diseaseEugenia Nikolsky, Alexandra J Lansky, Krishnankutty Sudhir, et al.
Journal of Interventional Cardiology|September 17, 2011
Performance of everolimus-eluting versus paclitaxel-eluting coronary stents in small vessels: results from the SPIRIT III and SPIRIT IV clinical trialsHiroki Ito, James B Hermiller, Manejeh Yaqub, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 31, 2009
Clinical and angiographic outcomes with an everolimus-eluting stent in large coronary arteries: the SPIRIT III 4.0 mm registryPaul C Gordon, Robert J Applegate, James B Hermiller, et al.
Indian Heart Journal|June 30, 2014
Three-year data from the XIENCE V INDIA study: safety and efficacy of XIENCE V in 1000 real world Indian patientsAshok Seth, Tejas M Patel, Marrianne Stuteville, et al.
Pageof 10